Tomoki Naoe
机构: Nagoya University, NHO Nagoya Medical Center
每年引用次数
引用次数
引用: 51,029
H-指数: 98
I10-指数 : 431
出版物: 881
Comparable profiles of the immunoglobulin heavy chain complementarity determining region (CDR)-3 in CD5+ and CD5- human cord blood B lymphocytes.
H Kiyoi , T Naoe , K Naito , R Ohno
Immunology 85 ( 2) 236 -240
6
1995
Case of acute monocytic leukemia brought to the second remission by allogeneic bone marrow transplantation but eventually developing subcutaneous blastoma
T Naoe , S Kimura , H Sao , A Hiraiwa
Gan to kagaku ryoho. Cancer & chemotherapy 10 ( 7) 1691 -1699
1983
Chromosome abnormalities and their clinical significance in leukemia and lymphoma
Y Nakano , T Naoe
Nihon rinsho. Japanese journal of clinical medicine 638 -641
1999
Autoantibodies to c-myc nuclear protein products in autoimmune disease.
T Naoe , H Shiku , K Yamada , T Yamauchi
Immunology 69 ( 1) 117 -120
9
1990
[A comparative clinical study on flucytosine alone and in combination with fluconazole in hematological malignancies: a multicenter study using the envelope method].
T Murate , M Ogura , M Tanaka , H Ariyoshi
The Journal of Antibiotics 47 ( 10) 1413 -1420
1
1994
[Human monoclonal antibodies with human-mouse hybridomas].
K Kato , K Yamada , H Shiku , T Naoe
Gan to kagaku ryoho. Cancer & chemotherapy 10 ( 12) 2575 -2581
1
1983
[Clinical study of high-dose chemotherapy with peripheral blood stem cell transplantation for poor-risk germ cell tumor].
M Gotoh , K Okamura , S Ohshima , H Yuba
Hinyokika kiyo. Acta urologica Japonica 45 ( 11) 793 -798
1999
[Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation].
T Naoe , N Hirabayashi , H Sao , T Matsuyama
The Japanese journal of clinical hematology 39 ( 1) 21 -26
1998
[A "retinoic acid syndrome" observed in two cases of acute promyelocytic leukemia].
M Aiso , R Ohno , A Horikoshi , Y Iizuka
The Japanese journal of clinical hematology 34 ( 9) 1044 -1049
3
1993
Distribution of TNF endogenously induced by various immunopotentiators and Lactobacillus casei in mice.
Y Kuroiwa , Y Kawazoe , M Takeda , S Ichikawa
in Vivo 6 ( 3) 247 -253
10
1992
Development of hyperthyroidism in donor and recipient after allogeneic bone marrow transplantation.
H Kiyoi , T Naoe , T Ichihashi , H Fukutani
Bone Marrow Transplantation 10 ( 4) 397 -398
12
1992
The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells
Y Kuwatsuka , M Minami , Y Minami , K Sugimoto
Blood Cancer Journal 1 ( 5) e17 -e17
10
2011
Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR-ABL-positive ALL.
S Mizuta , K Matsuo , T Maeda , T Yujiri
Blood Cancer Journal 2 ( 5)
21
2012
A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases
F Hayakawa , K Sugimoto , Y Harada , N Hashimoto
Blood Cancer Journal 3 ( 11)
112
2013
Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group
F Hayakawa , , T Sakura , T Yujiri
Blood Cancer Journal 4 ( 10)
54
2014
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.
E Togasaki , , J Takeda , K Yoshida
Blood Cancer Journal 7 ( 4)
29
2017
Array-based genomic resequencing of human leukemia
Y Yamashita , J Yuan , I Suetake , H Suzuki
Oncogene 29 ( 25) 3723 -3731
216
2010
PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML.
S Kurahashi , F Hayakawa , Y Miyata , T Yasuda
Oncogene 30 ( 15) 1822 -1830
25
2011
Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells.
H Kiyoi , T Naoe , K Horibe , R Ohno
Journal of Clinical Investigation 89 ( 3) 739 -746
29
1992
Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.
T Kobayashi , S Miyawaki , M Tanimoto , K Kuriyama
Journal of Clinical Oncology 14 ( 1) 204 -213
86
1996
Masamitsu Yanada Kazuyuki Shimada Keitaro Matsuo Yukio Kobayashi Miguel Sanz Hartmut Döhner francesco lo coco Clara D. Bloomfield, MD frederick appelbaum Yoshihiro Hatta Yukiya Yamamoto Hiroto Narimatsu Yukimasa Shiotsu Richard A. Larson Naoto Takahashi Wilson Miller Catriona Jamieson Pier Paolo Pandolfi